Internationally established transparent procedures in line with evidence-based medicine

Multidisciplinary approach in cooperation with our partners

Independence of interest groups in order to get quality expert statements

Value for money in using scarce resources in health care

Comprehensive expert assessments as a basis for political decisions

NIHO is an independent HTA institution that issues assessments and analyses according to a well-established European methodology (EUnetHTA) in line with the principles of evidence-based medicine. NIHO is a public institution with statutory funding and obligations which make it independent of politics and influences of the medical technology industry.

The main task of NIHO is to bring scientific approach and transparency to the decision-making processes in the health sector. NIHO studies vast amounts of information available on the subject and processes it in a form that is comprehensible to the decision-makers or authorities. NIHO does not issue decisions, this competence remains with the responsible authority, for the most part with the Ministry of Health of the Slovak Republic.

Published projects

Osimertinib (Tagrisso) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
11.07.2024
Published
Pembrolizumab (Keytruda) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
03.07.2024
Published
Bimekizumab (Bimzelx) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
11.06.2024
Published

Show all

Projects in progress

Talazoparib (Talzenna) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
10.07.2024
Projects in progress
Elranatamab (Elrexfio) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
02.07.2024
Projects in progress
Imlifidáza (Idefirix) – hodnotenie podľa zákona č. 358/2021 Z.z. účinného od 1.1.2024
17.06.2024
Projects in progress

Show all

Participation

Involving input from clinical experts and patients is essential for a truly comprehensive technology assessment.

en_GBEN
Skip to content